Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Arrhythmias

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 86 articles: HTML format

Single Articles

September 2023
1. EGBE AC, Miranda WR, Madhavan M, Abozied O, et al
   Right atrial dysfunction is associated with atrial arrhythmias in adults with repaired tetralogy of fallot.
   Am Heart J. 2023;263:141-150.
   PubMed     Abstract available
   
   
   August 2023
2. BISSON A, Lemrini Y, Romiti GF, Proietti M, et al
   Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: A French nationwide cohort study.
   Am Heart J. 2023 Aug 16:S0002-8703(23)00203-X. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   
3. KIR D, Van Houten HK, Walvatne KN, Behnken EM, et al
   Physicians' Perspectives on Percutaneous Left Atrial Appendage Occlusion for Patients with Atrial Fibrillation.
   Am Heart J. 2023 Aug 9:S0002-8703(23)00184-9. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   
4. DEMKOWICZ PC, Dhruva SS, Spatz ES, Beatty AL, et al
   Physician responses to apple watch-detected irregular rhythm alerts.
   Am Heart J. 2023;262:29-37.
   PubMed     Abstract available
   
   
   July 2023
5. VINEREANU D, Wojdyla DM, Alexander JH, Lopes RD, et al
   Heart Rate and Death and Hospitalization for Heart Failure in Patients with Persistent or Permanent Atrial Fibrillation: Insights from the ARISTOTLE Trial.
   Am Heart J. 2023 Jul 26:S0002-8703(23)00179-5. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   
6. PIPILAS DC, Khurshid S, Atlas SJ, Ashburner JM, et al
   Accuracy and Variability of Cardiologist Interpretation of Single Lead Electrocardiograms for Atrial Fibrillation: the VITAL-AF Trial.
   Am Heart J. 2023 Jul 12:S0002-8703(23)00173-4. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   June 2023
7. LOPES RD, de Barros E Silva PGM, Filho CRH, Cavalvante MA, et al
   The First Brazilian Cardiovascular Registry of Atrial Fibrillation: Primary Results of the RECALL Study.
   Am Heart J. 2023 Jun 15:S0002-8703(23)00162-X. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   
8. MADSEN CL, Park-Hansen J, Irmukhamedov A, Carranza CL, et al
   The Left Atrial Appendage Closure by Surgery-2 (LAACS-2) trial protocol Rationale and design of a randomized multicenter trial investigating if left atrial appendage closure prevents stroke in patients undergoing open-heart surgery irrespective of pre
   Am Heart J. 2023 Jun 9:S0002-8703(23)00147-3. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   
9. VIRTANEN JK, Hantunen S, Lamberg-Allardt C, Manson JE, et al
   The effect of vitamin D(3) supplementation on atrial fibrillation in generally healthy men and women -the Finnish Vitamin D Trial.
   Am Heart J. 2023 Jun 9:S0002-8703(23)00143-6. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   
10. KAR S, Doshi SK, Alkhouli M, Camm AJ, et al
    Rationale and Design of a Randomized Study Comparing the Watchman FLX Device to DOACs in Patients with Atrial Fibrillation.
    Am Heart J. 2023 Jun 4:S0002-8703(23)00140-0. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    April 2023
11. RAO VN, Cyr D, Wruck L, Sanders G, et al
    Electronic Health Record Characterization and Outcomes of Heart Failure with Preserved Ejection Fraction.
    Am Heart J. 2023 Apr 26:S0002-8703(23)00100-X. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
12. PUNDI K, Perino AC, Fan J, Din N, et al
    Association of CHA(2)DS(2)-VASc and HAS-BLED to Frailty and Frail Outcomes: From the TREAT-AF Study.
    Am Heart J. 2023 Apr 4:S0002-8703(23)00076-5. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
13. MILLS EW, Cassidy M, Sofer T, Tadros T, et al
    Evaluation of obstructive sleep apnea among consecutive patients with all patterns of atrial fibrillation using WatchPAT home sleep testing.
    Am Heart J. 2023 Apr 3:S0002-8703(23)00074-1. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    March 2023
14. HIJAZI Z, Lindback J, Oldgren J, Benz AP, et al
    Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scores.
    Am Heart J. 2023 Mar 27:S0002-8703(23)00073-X. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
15. RONG LQ, Franco AD, Rahouma M, Dimagli A, et al
    Postoperative pericardial effusion, pericardiotomy and atrial fibrillation: an explanatory analysis of the PALACS trial.
    Am Heart J. 2023 Mar 17:S0002-8703(23)00063-7. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
16. SUDO Y, Morimoto T, Tsushima R, Sogo M, et al
    P-wave Terminal Force in Lead V1 and Outcomes in Patients with Persistent Atrial Fibrillation Undergoing Catheter Ablation.
    Am Heart J. 2023 Mar 17:S0002-8703(23)00066-2. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
17. NGUFOR C, Yao X, Inselman JW, Ross JS, et al
    Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning method.
    Am Heart J. 2023 Mar 7:S0002-8703(23)00049-2. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    February 2023
18. LIU XX, Liu Q, Lai YW, Guo Q, et al
    Prospective randomized comparison between upgraded '2C3L' vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial design.
    Am Heart J. 2023 Feb 20:S0002-8703(23)00027-3. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
19. CONEN D, Popova E, Wang MK, Chan MTV, et al
    Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial.
    Am Heart J. 2023 Feb 6:S0002-8703(23)00025-X. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    January 2023
20. GOMEZ SE, Parizo J, Ermakov S, Larson J, et al
    Evaluation of the Association Between Circulating IL-1beta and Other Inflammatory Cytokines and Incident Atrial Fibrillation in a Cohort of Postmenopausal Women.
    Am Heart J. 2023 Jan 13:S0002-8703(23)00011-X. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
21. GIBSON CM, Steinhubl S, Lakkireddy D, Turakhia MP, et al
    Does Early Detection of Atrial Fibrillation Reduce the Risk of Thromboembolic Events? Rationale and Design of the Heartline Study.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00014-5. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    December 2022
22. LOPEZ-GALVEZ R, Rivera-Caravaca JM, Roldan V, Orenes-Pinero E, et al
    Imaging in atrial fibrillation: a way to assess atrial fibrosis and remodeling to assist decision-making.
    Am Heart J. 2022 Dec 13:S0002-8703(22)00329-5. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
23. HARRISON SL, Buckley BJR, Zheng Y, Hill A, et al
    Evaluation of Huawei Smart Wearables for Detection of Atrial Fibrillation in Patients Following Ischaemic Stroke: The Liverpool-Huawei Stroke Study.
    Am Heart J. 2022 Dec 6:S0002-8703(22)00324-6. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
24. SKIBNIEWSKI M, Venetsanos D, Ahlsson A, Batra G, et al
    Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registry.
    Am Heart J. 2022 Dec 5:S0002-8703(22)00321-0. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    November 2022
25. STAMBLER BS, Plat F, Sager PT, Lubkov V, et al
    Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia.
    Am Heart J. 2022;253:20-29.
    PubMed     Abstract available
    
    
    September 2022
26. ZEITLER EP, Bunch TJ, Khanna R, Fan X, et al
    Comparative risk of dementia among patients with atrial fibrillation treated with catheter ablation versus anti-arrhythmic drugs.
    Am Heart J. 2022;254:194-202.
    PubMed     Abstract available
    
    
    
27. BRIK T, Lucassen WAM, Harskamp RE, Karregat EPM, et al
    Personalized approach using wearable technology for early detection of Atrial Fibrillation in high-risk primary care patients (PATCH-AF): study protocol for a cluster randomized controlled trial.
    Am Heart J. 2022 Sep 10. pii: S0002-8703(22)00185.
    PubMed     Abstract available
    
    
    
28. NAKAMARU R, Ikemura N, Spertus JA, Kimura T, et al
    Rate versus Rhythm Control in Patients with Newly Diagnosed Atrial Fibrillation: Effects of the Treatment Timing on Health Status Outcomes.
    Am Heart J. 2022 Sep 10. pii: S0002-8703(22)00187.
    PubMed     Abstract available
    
    
    August 2022
29. NERY PB, Wells GA, Verma A, Joza J, et al
    CHARACTERIZATION OF ARRHYTHMIA SUBSTRATE TO ABLATE PERSISTENT ATRIAL FIBRILLATION (COAST-AF): RANDOMIZED CONTROLLED TRIAL DESIGN AND RATIONALE.
    Am Heart J. 2022 Aug 25. pii: S0002-8703(22)00181.
    PubMed     Abstract available
    
    
    
30. FRIEDMAN DJ, Pierre D, Wang Y, Gambone L, et al
    Development and Validation of an Automated Algorithm for Endpoint Adjudication for a Large U.S. National Registry: Short Title: Automated Adjudication Algorithm.
    Am Heart J. 2022 Aug 22. pii: S0002-8703(22)00168.
    PubMed     Abstract available
    
    
    
31. MURRAY EM, Greene SJ, Rao VN, Sun JL, et al
    Machine Learning to Define Phenotypes and Outcomes of Patients Hospitalized for Heart Failure with Preserved Ejection Fraction: Findings from ASCEND-HF.
    Am Heart J. 2022 Aug 22. pii: S0002-8703(22)00171.
    PubMed     Abstract available
    
    
    July 2022
32. SCHOLTEN J, Jansen WPJ, Horsthuis T, Mahes AD, et al
    Six-lead device superior to single-lead smartwatch ECG in atrial fibrillation detection.
    Am Heart J. 2022 Jul 15. pii: S0002-8703(22)00143.
    PubMed     Abstract available
    
    
    
33. WINSLOW U, Sakthivel T, Zheng C, Bosselmann H, et al
    Targeted potassium levels to decrease arrhythmia burden in high risk patients with cardiovascular diseases (POTCAST): Study protocol for a randomized controlled trial.
    Am Heart J. 2022 Jul 11. pii: S0002-8703(22)00145.
    PubMed     Abstract available
    
    
    June 2022
34. DIXON D, Patel J, Spence R, Talasaz A, et al
    Select Drug-Drug Interactions with Colchicine and Cardiovascular Medications: A Review.
    Am Heart J. 2022 Jun 14. pii: S0002-8703(22)00126.
    PubMed     Abstract available
    
    
    
35. MAGNANI JW, Ferry D, Swabe G, Martin D, et al
    Design and rationale of the Mobile health intervention for rural atrial fibrillation.
    Am Heart J. 2022 Jun 9. pii: S0002-8703(22)00117.
    PubMed     Abstract available
    
    
    
36. REIFFEL JA
    The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease - Fact or fallacy.
    Am Heart J. 2022;248:163-164.
    PubMed    
    
    
    May 2022
37. AULIN J, Hijazi Z, Lindback J, Alexander JH, et al
    Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multistate model.
    Am Heart J. 2022 May 12. pii: S0002-8703(22)00091.
    PubMed     Abstract available
    
    
    
38. OKAZAKI O, Higashino Y, Yokoya K, An Y, et al
    Prognosis of elderly non-valvular atrial fibrillation patients stratified by B-type natriuretic peptide: ELDERCARE-AF subanalysis.
    Am Heart J. 2022 May 11. pii: S0002-8703(22)00094.
    PubMed     Abstract available
    
    
    
39. GWAG HB, Kim HR, Park SJ, Kim J, et al
    The efficacy of single-lead implantable cardioverter-defibrillator with atrial sensing dipole to detect atrial fibrillation and to reduce inappropriate therapy according to atrial sensing ON or OFF: Rationale and design of the SMART-CONTROL study, a p
    Am Heart J. 2022 May 11. pii: S0002-8703(22)00090.
    PubMed     Abstract available
    
    
    
40. LOPEZ-GALVEZ R, Marin F, Rivera-Caravaca JM
    Predicting heart failure in atrial fibrillation patients: What about using biomarkers?
    Am Heart J. 2022 May 7. pii: S0002-8703(22)00092.
    PubMed    
    
    
    
41. HUIJBOOM HFM, Maarse M, Aarnink E, van Dijk VF, et al
    COMPARE LAAO: Rationale and design of the randomized controlled trial 'COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagul
    Am Heart J. 2022 May 7. pii: S0002-8703(22)00085.
    PubMed     Abstract available
    
    
    
42. WAZNI O, Boersma L, Healey JS, Mansour M, et al
    Comparison of Anticoagulation with Left Atrial Appendage Closure after AF Ablation: Rationale and Design of the OPTION randomized trial.
    Am Heart J. 2022 May 5. pii: S0002-8703(22)00088.
    PubMed     Abstract available
    
    
    
43. GAO W, Zhong X, Ma Y, Huang D, et al
    A Randomized Multicenter Trial to Evaluate Early Invasive Strategy for Patients with Acute ST-segment Elevation Myocardial Infarction Presenting 24-48 Hours from Symptom Onset: protocol of the RESCUE-MI study.
    Am Heart J. 2022 May 4. pii: S0002-8703(22)00087.
    PubMed     Abstract available
    
    
    April 2022
44. SINGER DE, Atlas SJ, Go AS, Lopes RD, et al
    ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and Design of the GUARD-AF Randomized Trial of Screening for Atrial Fibrillation with a 14-day Patch-Based Continuous ECG Monitor.
    Am Heart J. 2022 Apr 23. pii: S0002-8703(22)00080.
    PubMed     Abstract available
    
    
    February 2022
45. NAIR GM, Birnie DH, Wells GA, Nery PB, et al
    Augmented Wide Area Circumferential Catheter Ablation for Reduction of Atrial Fibrillation Recurrence (AWARE) Trial: Design and Rationale.
    Am Heart J. 2022 Feb 24. pii: S0002-8703(22)00043.
    PubMed     Abstract available
    
    
    
46. JONES AE, McCarty MM, Brito JP, Noseworthy PA, et al
    Randomized Evaluation of Decision Support Interventions for Atrial Fibrillation: Rationale and Design of the RED-AF study.
    Am Heart J. 2022 Feb 23. pii: S0002-8703(22)00042.
    PubMed     Abstract available
    
    
    
47. CHO MS, Kang DY, Oh YS, Lee CH, et al
    Edoxaban-Based Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Stable Coronary Disease: Rationale and Design of the Randomized EPIC-CAD Trial.
    Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00023.
    PubMed     Abstract available
    
    
    
48. CHANG PC, Wen MS, Chou CC, Wang CC, et al
    Atrial Fibrillation Detection Using Ambulatory Smartwatch Photoplethysmography and Validation with Simultaneous Holter Recording.
    Am Heart J. 2022 Feb 4. pii: S0002-8703(22)00028.
    PubMed     Abstract available
    
    
    January 2022
49. BAYKANER T, Pundi K, Lin B, Lu Y, et al
    The ENHANCE-AF Clinical Trial to Evaluate an Atrial Fibrillation Shared Decision-Making Pathway: Rationale and Study Design.
    Am Heart J. 2022 Jan 26. pii: S0002-8703(22)00013.
    PubMed     Abstract available
    
    
    
50. KLINGENBERG R, Stahli BE, Heg D, Denegri A, et al
    Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial.
    Am Heart J. 2022 Jan 26. pii: S0002-8703(22)00010.
    PubMed     Abstract available
    
    
    
51. ECKMAN MH, Wise R, Knochelmann C, Mardis R, et al
    Electronic Health Record-Embedded Decision Support to Reduce Stroke Risk in Patients with Atrial Fibrillation - Study Protocol.
    Am Heart J. 2022 Jan 23. pii: S0002-8703(22)00012.
    PubMed     Abstract available
    
    
    
52. GENCER B, Eisen A, Berger D, Nordio F, et al
    Edoxaban vs. Warfarin in High-risk Patients with Atrial Fibrillation: A Comprehensive Analysis of High-Risk Subgroups.
    Am Heart J. 2022 Jan 3. pii: S0002-8703(21)00499.
    PubMed     Abstract available
    
    
    
53. FARJAT AE, Virdone S, Thomas LE, Kakkar AK, et al
    The importance of the design of observational studies in comparative effectiveness research: Lessons from the GARFIELD-AF and ORBIT-AF registries.
    Am Heart J. 2022;243:110-121.
    PubMed     Abstract available
    
    
    December 2021
54. HIGGINS AY, Annapureddy AR, Wang Y, Minges KE, et al
    Risk and Predictors of Mortality After Implantable Cardioverter-Defibrillator Implantation in Patients with Sarcoid Cardiomyopathy.
    Am Heart J. 2021 Dec 27. pii: S0002-8703(21)00491.
    PubMed     Abstract available
    
    
    
55. ULLAL AJ, Holmes DN, Lytle BL, Matsouaka RA, et al
    Achievement and Quality Measure Attainment in Patients Hospitalized with Atrial Fibrillation: Results from the Get With The Guidelines(R) - Atrial Fibrillation (GWTG-AFIB) Registry.
    Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00475.
    PubMed     Abstract available
    
    
    
56. PAVLOVIC N, Chierchia GB, Velagic V, Hermida JS, et al
    Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptoms.
    Am Heart J. 2021;242:103-114.
    PubMed     Abstract available
    
    
    November 2021
57. STEINBERG BA, Li Z, Shrader P, Chew DS, et al
    Clinical Investigations Bimodal Distribution of Atrial Fibrillation Burden in 3 Distinct Cohorts: What is 'Paroxysmal' Atrial Fibrillation?
    Am Heart J. 2021 Nov 24. pii: S0002-8703(21)00464.
    PubMed     Abstract available
    
    
    
58. ANTONIO GUTIERREZ J, Ruff CT, Aday AW, Gu L, et al
    Electronic Alerts to Initiate Anticoagulation Dialogue in Patients with Atrial Fibrillation.
    Am Heart J. 2021 Nov 19. pii: S0002-8703(21)00452.
    PubMed     Abstract available
    
    
    
59. CHEW DS, Li Z, Steinberg BA, O'Brien E, et al
    Association between Economic and Arrhythmic Burden of Paroxysmal Atrial Fibrillation in Patients with Cardiac Implanted Electronic Devices.
    Am Heart J. 2021 Nov 17. pii: S0002-8703(21)00450.
    PubMed     Abstract available
    
    
    
60. MERT GO, Babayigit E, Gorenek B
    The value of performing thorough echocardiography in patients with coronary heart disease and atrial fibrillation.
    Am Heart J. 2021;241:121.
    PubMed    
    
    
    
61. TOMASDOTTIR M, Held C, Wallentin L, Hijazi Z, et al
    Natriuretic peptides and incident atrial fibrillation.
    Am Heart J. 2021;241:120.
    PubMed    
    
    
    
62. DAILEY-SCHWARTZ AL, Dyal JA, Mahle WT, Oster ME, et al
    Implementation of a practice plan for the outpatient cardiac evaluation of children after acute SARS-CoV-2 infection and a report of outcomes.
    Am Heart J. 2021;241:83-86.
    PubMed     Abstract available
    
    
    October 2021
63. AKDIS D, Chen L, Saguner AM, Zhang N, et al
    Novel Plasma Biomarkers Predicting Biventricular Involvement in Arrhythmogenic Right Ventricular Cardiomyopathy: Novel Biomarkers in ARVC.
    Am Heart J. 2021 Oct 28. pii: S0002-8703(21)00441.
    PubMed     Abstract available
    
    
    
64. ARITA VA, Santema BT, De With RR, Nguyen BO, et al
    Atrial function in paroxysmal AF patients with and without heart failure with preserved ejection fraction: data from the AF-RISK study.
    Am Heart J. 2021 Oct 21. pii: S0002-8703(21)00435.
    PubMed     Abstract available
    
    
    
65. PICCINI JP, Ahlsson A, Dorian P, Gillinov MA, et al
    Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA Study.
    Am Heart J. 2021 Oct 20. pii: S0002-8703(21)00366.
    PubMed     Abstract available
    
    
    
66. RASMUSSEN PV, Blanche P, Dalgaard F, Gislason GH, et al
    Electrical cardioversion of atrial fibrillation and the risk of brady-arrhythmic events: Rasmussen et al: Electrical cardioversion and bradycardia.
    Am Heart J. 2021 Oct 16. pii: S0002-8703(21)00434.
    PubMed     Abstract available
    
    
    
67. CHIENG D, Sugumar H, Ling LH, Segan L, et al
    Catheter Ablation for Persistent Atrial Fibrillation: a Multicentre Randomised Trial of Pulmonary Vein Isolation (PVI) versus PVI with Posterior Left Atrial Wall Isolation (PWI) - the CAPLA Study: CAPLA: randomised trial for persistent AF.
    Am Heart J. 2021 Oct 4. pii: S0002-8703(21)00245.
    PubMed     Abstract available
    
    
    September 2021
68. KORSHOLM K, Damgaard D, Valentin JB, Packer EJS, et al
    Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Rationale and Design of the Multicenter Randomized Occlusion-AF Trial.
    Am Heart J. 2021 Sep 16. pii: S0002-8703(21)00226.
    PubMed     Abstract available
    
    
    
69. BURNHAM TS, May HT, Bair TL, Anderson JA, et al
    Long-term Outcomes in Patients Treated with Flecainide for Atrial Fibrillation with Stable Coronary Artery Disease.
    Am Heart J. 2021 Sep 16. pii: S0002-8703(21)00211.
    PubMed     Abstract available
    
    
    
70. KIM K, Yang PS, Jang E, Yu HT, et al
    Increased risk of ischemic stroke and systemic embolism in hyperthyroidism-related atrial fibrillation: A nationwide cohort study.
    Am Heart J. 2021 Sep 1. pii: S0002-8703(21)00224.
    PubMed     Abstract available
    
    
    August 2021
71. DAWWAS GK, Barnes GD, Dietrich E, Cuker A, et al
    Cardiovascular and major bleeding outcomes with antiplatelet and direct oral anticoagulants in patients with acute coronary syndrome and atrial fibrillation A population-based analysis.
    Am Heart J. 2021 Aug 24. pii: S0002-8703(21)00212.
    PubMed     Abstract available
    
    
    
72. BONNESEN MP, Diederichsen SZ, Isaksen JL, Frederiksen KS, et al
    Atrial Fibrillation Burden and Cognitive Decline in Elderly Patients Undergoing Continuous Monitoring.
    Am Heart J. 2021 Aug 21. pii: S0002-8703(21)00204.
    PubMed     Abstract available
    
    
    
73. HAWKINS NM, Er L, Sandhu RK, Kaul P, et al
    Validity of different dose reduction criteria for apixaban.
    Am Heart J. 2021;238:12-15.
    PubMed     Abstract available
    
    
    July 2021
74. CHRISTENSEN DM, Butt JH, Fosbol E, Kober L, et al
    Admission Rates During a Second COVID-19 Lockdown.
    Am Heart J. 2021 Jul 15. pii: S0002-8703(21)00180.
    PubMed     Abstract available
    
    
    
75. FREYER L, von Stulpnagel L, Spielbichler P, Sappler N, et al
    Rationale and design of a digital trial using smartphones to detect subclinical atrial fibrillation in a population at risk: The eHealth-based Bavarian Alternative Detection of Atrial Fibrillation (eBRAVE-AF) trial.
    Am Heart J. 2021 Jul 9. pii: S0002-8703(21)00164.
    PubMed     Abstract available
    
    
    June 2021
76. KUMAR N, Xu H, Garg N, Pandey A, et al
    Patient Characteristics, Care Patterns, and Outcomes of Atrial Fibrillation Associated Hospitalizations in Patients with Chronic Kidney Disease and End-Stage Renal Disease.
    Am Heart J. 2021 Jun 30. pii: S0002-8703(21)00175.
    PubMed     Abstract available
    
    
    
77. WHEELOCK KM, Kratz A, Lathkar-Pradhan S, Najarian K, et al
    Association between Symptoms, Affect and Heart Rhythm in Patients with Persistent or Paroxysmal Atrial Fibrillation: An Ambulatory Pilot Study.
    Am Heart J. 2021 Jun 19. pii: S0002-8703(21)00150.
    PubMed     Abstract available
    
    
    
78. SZUMMER K, Perino AC, Fan J, Kothari M, et al
    Association of kidney function and atrial fibrillation progression to clinical outcomes in patients with cardiac implantable electronic devices.
    Am Heart J. 2021 Jun 9. pii: S0002-8703(21)00149.
    PubMed     Abstract available
    
    
    May 2021
79. KITTIPIBUL V, Blumer V, Hernandez GA, Fudim M, et al
    Pre-operative Atrial Fibrillation and Early Right Ventricular Failure after Left Ventricular Assist Device Implantation: A Systematic Review and Meta-Analysis.
    Am Heart J. 2021 May 23. pii: S0002-8703(21)00138.
    PubMed     Abstract available
    
    
    
80. YAO X, Attia ZI, Behnken EM, Walvatne K, et al
    Batch Enrollment for an Artificial Intelligence-Guided Intervention to Lower Neurologic Events in Patients with Undiagnosed Atrial Fibrillation (BEAGLE): Rationale and design of a digital clinical trial.
    Am Heart J. 2021 May 22. pii: S0002-8703(21)00135.
    PubMed     Abstract available
    
    
    
81. HESS PL, Gosch KL, Jani SM, Varosy PD, et al
    Use of Oral Anticoagulants in Patients with Valvular Atrial Fibrillation: Findings From the NCDR PINNACLE Registry(R).
    Am Heart J. 2021 May 22. pii: S0002-8703(21)00120.
    PubMed     Abstract available
    
    
    
82. GRUBB CS, Truby LK, Topkara VK, Bohnen MS, et al
    Advanced Heart Failure Patients Supported with Ambulatory Inotropic Therapy: What Defines Success of Therapy?
    Am Heart J. 2021 May 10. pii: S0002-8703(21)00121.
    PubMed     Abstract available
    
    
    
83. MADSEN JMM, Jacobsen MRR, Sabbah M, Topal DGG, et al
    Long-Term Prognostic Outcomes and Implication of Oral Anticoagulants in Patients with New-Onset Atrial Fibrillation following ST-Segment Elevation Myocardial Infarction.
    Am Heart J. 2021 May 3. pii: S0002-8703(21)00114.
    PubMed     Abstract available
    
    
    April 2021
84. LUBITZ SA, Faranesh AZ, Atlas SJ, McManus DD, et al
    Rationale and Design of a Large Population Study to Validate Software for the Assessment of Atrial Fibrillation from Data Acquired by a Consumer Tracker or Smartwatch: The Fitbit Heart Study.
    Am Heart J. 2021 Apr 15. pii: S0002-8703(21)00093.
    PubMed     Abstract available
    
    
    
85. MARTIN AC, Hausleiter J, Karam N
    Intra-procedural unfractionated heparin monitoring and uninterrupted direct oral anticoagulants: An unheeded issue in transcatheter mitral valve repair procedures.
    Am Heart J. 2021;234:136-137.
    PubMed    
    
    
    March 2021
86. KIVINIEMI T, Bustamante-Munguira J, Olsson C, Jeppsson A, et al
    A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery - LAA-CLOSURE trial protocol.
    Am Heart J. 2021 Mar 30. pii: S0002-8703(21)00087.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: